Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AR › LITTLE ROCK › NATURAL STATE GENOMICS LLC

NATURAL STATE GENOMICS LLC

NPI: 1861032633 · LITTLE ROCK, AR 72212 · Clinical Medical Laboratory · NPI assigned 01/09/2020

$4.34M
Total Medicaid Paid
279,665
Total Claims
115,749
Beneficiaries
38
Codes Billed
2020-05
First Month
2024-02
Last Month

Provider Details

Authorized OfficialHONEYCUTT, CASEY (PRESIDENT)
NPI Enumeration Date01/09/2020

Related Entities

Other providers sharing the same authorized official: HONEYCUTT, CASEY

ProviderCityStateTotal Paid
NATURAL STATE LABORATORIES, LLC LITTLE ROCK AR $513K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 34,120 $874K
2021 134,542 $1.98M
2022 105,242 $1.44M
2023 4,943 $37K
2024 818 $9K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 135,611 52,841 $3.82M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 17,948 8,610 $477K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 267 146 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,104 944 $6K
87481 1,040 929 $5K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 82 43 $5K
87640 1,042 948 $5K
87653 992 900 $4K
87500 816 756 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 114,600 44,366 $3K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 210 198 $3K
87109 586 543 $1K
87631 28 27 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 175 146 $746.09
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 297 261 $701.68
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 256 222 $692.72
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 111 105 $636.54
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 176 146 $543.67
87641 297 261 $524.86
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 272 131 $478.86
87181 297 261 $387.95
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 18 17 $359.25
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,412 1,954 $349.33
87634 17 16 $173.32
87581 99 93 $150.36
87541 99 93 $150.36
87486 104 96 $137.87
87498 17 16 $101.34
87106 61 57 $58.50
81439 64 64 $0.00
81408 64 64 $0.00
81404 64 64 $0.00
81405 64 64 $0.00
81406 64 64 $0.00
81403 64 64 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 102 99 $0.00
81407 64 64 $0.00
87496 81 76 $0.00